BIOMARIN PHARMACEUTICAL INC's ticker is and the CUSIP is 09061GAH4. A total of 51 filers reported holding BIOMARIN PHARMACEUTICAL INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $17,000 | -79.5% | 14,000 | -82.3% | 0.00% | – |
| Q1 2020 | $83,000 | +176.7% | 79,288 | +168.0% | 0.00% | – |
| Q4 2019 | $30,000 | +3.4% | 29,582 | +1.8% | 0.00% | – |
| Q2 2019 | $29,000 | -43.1% | 29,068 | -43.2% | 0.00% | – |
| Q1 2019 | $51,000 | +155.0% | 51,157 | +157.2% | 0.00% | – |
| Q4 2018 | $20,000 | -4.8% | 19,888 | -6.7% | 0.00% | – |
| Q3 2018 | $21,000 | +5.0% | 21,315 | +5.5% | 0.00% | – |
| Q2 2018 | $20,000 | -73.3% | 20,204 | -73.6% | 0.00% | – |
| Q1 2018 | $75,000 | -25.7% | 76,550 | -24.2% | 0.00% | – |
| Q4 2017 | $101,000 | – | 101,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SHENKMAN CAPITAL MANAGEMENT INC | 16,732,000 | $16,408,385 | 1.23% |
| SONA ASSET MANAGEMENT (US) LLC | 23,125,000 | $22,451,923 | 0.93% |
| SSI INVESTMENT MANAGEMENT LLC | 8,726,000 | $8,464,220 | 0.69% |
| PFM Health Sciences, LP | 15,000,000 | $14,587,500 | 0.69% |
| RWC Asset Management LLP | 10,000,000 | $9,709,000 | 0.63% |
| Sonora Investment Management Group, LLC | 6,245,000 | $6,108,182 | 0.52% |
| Paloma Partners Management Co | 10,006,000 | $9,733,285 | 0.34% |
| MACKAY SHIELDS LLC | 9,891,000 | $9,594,270 | 0.26% |
| PALISADE CAPITAL MANAGEMENT, LP | 8,704,000 | $8,455,066 | 0.24% |
| Centiva Capital, LP | 10,000,000 | $9,716,288 | 0.21% |